Found: 200
Select item for more details and to access through your institution.
Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 4, p. 774, doi. 10.1002/ana.27032
- By:
- Publication type:
- Article
Mechanisms of peripheral levodopa resistance in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00321-y
- By:
- Publication type:
- Article
Factors associated with mortality in early stages of parkinsonism.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00329-4
- By:
- Publication type:
- Article
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00249-9
- By:
- Publication type:
- Article
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00172-z
- By:
- Publication type:
- Article
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41531-020-00124-z
- By:
- Publication type:
- Article
POTENTIAL PITFALLS IN THE ANALYSIS OF CSF BIOMARKERS IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA.
- Published in:
- 2007
- By:
- Publication type:
- Letter
MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01257-9
- By:
- Publication type:
- Article
Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-00972-z
- By:
- Publication type:
- Article
CSF Tau, Aβ<sub>42</sub>, and MHPG Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 27, n. 2, p. 377, doi. 10.3233/JAD-2011-110482
- By:
- Publication type:
- Article
Do Amyloid β-associated Factors Co-deposit with Aβ in Mouse Models for Alzheimer's Disease?
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 2, p. 345, doi. 10.3233/JAD-2010-100711
- By:
- Publication type:
- Article
CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 1, p. 87, doi. 10.3233/JAD-2010-100186
- By:
- Publication type:
- Article
CSF Neurofilament Proteins Levels are Elevated in Sporadic Creutzfeldt-Jakob Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 2, p. 569, doi. 10.3233/JAD-2010-090649
- By:
- Publication type:
- Article
CSF Studies Facilitate DNA Diagnosis in Familial Alzheimer's Disease Due to a Presenilin-1 Mutation.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 17, n. 1, p. 53, doi. 10.3233/JAD-2009-1038
- By:
- Publication type:
- Article
Cerebrospinal Fluid α-Synuclein Does Not Discriminate Between Dementia Disorders.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 2, p. 363, doi. 10.3233/JAD-2009-0955
- By:
- Publication type:
- Article
Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 6, p. 1494, doi. 10.1002/eji.202048580
- By:
- Publication type:
- Article
Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Shotgun proteomics for the discovery of protein biomarkers for cerebral amyloid angiopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076050
- By:
- Publication type:
- Article
Identification of CSF biomarkers for cerebral amyloid angiopathy using a targeted proteomics approach.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076410
- By:
- Publication type:
- Article
Tissue inhibitor of matrix metalloproteinases 4: a novel marker associated with CAA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076737
- By:
- Publication type:
- Article
Full complement activation is associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076151
- By:
- Publication type:
- Article
Tissue inhibitor of matrix metalloproteinases 4: a novel marker associated with CAA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076737
- By:
- Publication type:
- Article
Full complement activation is associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076151
- By:
- Publication type:
- Article
Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1788, doi. 10.1002/alz.12506
- By:
- Publication type:
- Article
Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 1, p. 10, doi. 10.1002/alz.12366
- By:
- Publication type:
- Article
Prevalence of sporadic cerebral amyloid angiopathy: A systematic review and meta‐analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052158
- By:
- Publication type:
- Article
Decreased purine metabolite levels in cerebrospinal fluid of transgenic cerebral amyloid angiopathy rats.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054334
- By:
- Publication type:
- Article
Amyloid‐βeta peptides in CSF and plasma discriminate cerebral amyloid angiopathy from controls.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053858
- By:
- Publication type:
- Article
A disbalance of matrix metalloproteinases and their inhibitors in the cerebrospinal fluid from patients with cerebral amyloid angiopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052850
- By:
- Publication type:
- Article
Urokinase plasminogen activator (uPA) as a novel biomarker for cerebral amyloid angiopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052082
- By:
- Publication type:
- Article
Platelet‐derived growth factor receptor‐beta as a potential CSF biomarker for Alzheimer's disease: Biomarkers (non‐neuroimaging) / Differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042924
- By:
- Publication type:
- Article
Neuroleukin: A potential cerebrospinal fluid biomarker for Alzheimer's disease: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042741
- By:
- Publication type:
- Article
Urokinase plasminogen activator (uPA) as a novel biomarker for cerebral amyloid angiopathy: Biomarkers (non‐neuroimaging) / novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042512
- By:
- Publication type:
- Article
Metabolomics biomarker discovery in cerebrospinal fluid for cerebral amyloid angiopathy: Biomarkers (non‐neuroimaging) / novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041934
- By:
- Publication type:
- Article
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 742, doi. 10.1016/j.jalz.2019.01.015
- By:
- Publication type:
- Article
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 10, p. 1313, doi. 10.1016/j.jalz.2018.05.008
- By:
- Publication type:
- Article
P3‐246: C‐REACTIVE PROTEIN, PLASMA AMYLOID BETA LEVELS AND MRI MARKERS: THE ROTTERDAM STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1166, doi. 10.1016/j.jalz.2018.06.1605
- By:
- Publication type:
- Article
P3‐232: THE ASSOCIATION BETWEEN BLOOD‐BRAIN‐BARRIER DYSFUNCTION AND CSF P‐TAU IS MEDIATED BY BETA‐AMYLOID IN THE PRESENCE OF ELEVATED IL‐6.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1160, doi. 10.1016/j.jalz.2018.06.1591
- By:
- Publication type:
- Article
O3‐09‐04: PLASMA AMYLOID β LEVELS, CEREBRAL ATROPHY AND DEMENTIA RISK: THE ROTTERDAM STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1037, doi. 10.1016/j.jalz.2018.06.2822
- By:
- Publication type:
- Article
Glycoproteomics in Cerebrospinal Fluid Reveals Brain-Specific Glycosylation Changes.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1937, doi. 10.3390/ijms24031937
- By:
- Publication type:
- Article
Valuing biomarker diagnostics for dementia care: enhancing the reflection of patients, their care-givers and members of the wider public.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism.
- Published in:
- Neuroradiology, 2015, v. 57, n. 7, p. 655, doi. 10.1007/s00234-015-1515-7
- By:
- Publication type:
- Article
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0395-6
- By:
- Publication type:
- Article
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0359-x
- By:
- Publication type:
- Article
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0328-9
- By:
- Publication type:
- Article
Current state and future directions of neurochemical biomarkers for Alzheimer's disease.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 11, p. 1421, doi. 10.1515/CCLM.2007.320
- By:
- Publication type:
- Article
Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2003, v. 41, n. 3, p. 331, doi. 10.1515/CCLM.2003.053
- By:
- Publication type:
- Article
LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P924, doi. 10.1016/j.jalz.2017.07.359
- By:
- Publication type:
- Article